Curated News
By: NewsRamp Editorial Staff
September 27, 2024

Aclarion, Inc. Utilizes Nociscan Solution to Understand Modic Changes in Chronic Low Back Pain Patients

Reddit Discuss on RedditDiscuss on Substack SubstackDiscuss on Telegram TelegramView History of this news story on GitHub Github
Source News Release

TLDR

  • Aclarion's Nociscan solution provides critical insights into the location of a patient's low back pain, giving clinicians a competitive advantage in optimizing treatment strategies.
  • The Nociscan solution uses MR Spectroscopy (MRS) to measure intradiscal propionic acid (PA) levels adjacent to vertebral endplates, clarifying Modic changes (MC) etiology and informing better treatment decisions.
  • Aclarion's innovative research and Nociscan technology aim to provide personalized treatment plans for chronic low back pain patients, ultimately improving patient outcomes and quality of life.
  • The results challenge the notion that the disc environment is sterile, providing an interesting and educational insight into the causes of chronic low back pain.

Impact - Why it Matters

This news matters because it reveals groundbreaking research that challenges the conventional understanding of chronic low back pain. The findings could lead to better treatment decisions and personalized care for millions of people suffering from spinal degeneration and low back pain worldwide.

Summary

Aclarion, Inc., a healthcare technology company, utilized the Nociscan solution to better understand Modic changes (MC) in patients suffering from chronic low back pain (cLBP). The company presented a prospective study at the 50th International Society for the Study of the Lumbar Spine Annual Meeting 2024. The study compared intradiscal propionic acid (PA) levels adjacent to vertebral endplates with MC, using MR Spectroscopy (MRS) and Nociscan.

The study challenged the notion that the disc environment is sterile and suggested that PA levels may be useful for understanding why some patients with MC improve or respond to treatment while others do not. Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine, providing critical insights into the location of a patient’s low back pain.

Source Statement

This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Aclarion, Inc. Utilizes Nociscan Solution to Understand Modic Changes in Chronic Low Back Pain Patients

blockchain registration record for the source press release.